On Friday, 89bio Inc (NASDAQ: ETNB) opened lower -15.89% from the last session, before settling in for the closing price of $6.86. Price fluctuations for ETNB have ranged from $5.99 to $11.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 42.05% at the time writing. With a float of $140.33 million, this company’s outstanding shares have now reached $145.98 million.
The extent of productivity of a business whose workforce counts for 93 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
89bio Inc (ETNB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 89bio Inc is 3.88%, while institutional ownership is 89.70%. The most recent insider transaction that took place on Jan 30 ’25, was worth 49,999,994. In this transaction Director of this company bought 5,714,285 shares at a rate of $8.75, taking the stock ownership to the 19,554,319 shares. Before that another transaction happened on Jan 22 ’25, when Company’s Director bought 10,000 for $6.71, making the entire transaction worth $67,100. This insider now owns 25,000 shares in total.
89bio Inc (ETNB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.45% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Check out the current performance indicators for 89bio Inc (ETNB). In the past quarter, the stock posted a quick ratio of 13.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.43, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
The latest stats from [89bio Inc, ETNB] show that its last 5-days average volume of 2.38 million was inferior to 2.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 12.07%. Additionally, its Average True Range was 0.78.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 3.50%, which indicates a significant decrease from 5.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 123.38% in the past 14 days, which was higher than the 92.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.09, while its 200-day Moving Average is $8.40. Now, the first resistance to watch is $6.53. This is followed by the second major resistance level at $7.29. The third major resistance level sits at $7.78. If the price goes on to break the first support level at $5.28, it is likely to go to the next support level at $4.79. The third support level lies at $4.03 if the price breaches the second support level.
89bio Inc (NASDAQ: ETNB) Key Stats
There are currently 145,984K shares outstanding in the company with a market cap of 842.33 million. Presently, the company’s annual sales total 0 K according to its annual income of -367,080 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -118,350 K.
